Viloxazine HCl in the treatment of endogenous depression: A standard (imipramine) controlled clinical study

Joseph Patrick McEvoy, J. Libiger, W. H. Wilson, T. A. Ban, S. Berney, W. Guy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In a four week, double-blind clinical trial, 20 patients with endogenous depression were randomly assigned to treatment with either viloxazine or imipramine. Statistically significant improvement was observed on the Hamilton Psychiatric Rating Scales for Depression and Anxiety for both treatment groups. There were no differences between the two treatment groups in the type, incidence, or severity of treatment emergent symptoms. No medication-related abnormalities in clinical laboratory values occurred in either treatment group.

Original languageEnglish (US)
Pages (from-to)111-112
Number of pages2
JournalJournal of Clinical Psychiatry
Volume43
Issue number3
StatePublished - May 5 1982

Fingerprint

Viloxazine
Imipramine
Depressive Disorder
Therapeutics
Psychiatry
Anxiety
Clinical Studies
Clinical Trials
Depression
Incidence

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Viloxazine HCl in the treatment of endogenous depression : A standard (imipramine) controlled clinical study. / McEvoy, Joseph Patrick; Libiger, J.; Wilson, W. H.; Ban, T. A.; Berney, S.; Guy, W.

In: Journal of Clinical Psychiatry, Vol. 43, No. 3, 05.05.1982, p. 111-112.

Research output: Contribution to journalArticle

McEvoy, Joseph Patrick ; Libiger, J. ; Wilson, W. H. ; Ban, T. A. ; Berney, S. ; Guy, W. / Viloxazine HCl in the treatment of endogenous depression : A standard (imipramine) controlled clinical study. In: Journal of Clinical Psychiatry. 1982 ; Vol. 43, No. 3. pp. 111-112.
@article{782e6d3163d944b3b5ad8b7829127be0,
title = "Viloxazine HCl in the treatment of endogenous depression: A standard (imipramine) controlled clinical study",
abstract = "In a four week, double-blind clinical trial, 20 patients with endogenous depression were randomly assigned to treatment with either viloxazine or imipramine. Statistically significant improvement was observed on the Hamilton Psychiatric Rating Scales for Depression and Anxiety for both treatment groups. There were no differences between the two treatment groups in the type, incidence, or severity of treatment emergent symptoms. No medication-related abnormalities in clinical laboratory values occurred in either treatment group.",
author = "McEvoy, {Joseph Patrick} and J. Libiger and Wilson, {W. H.} and Ban, {T. A.} and S. Berney and W. Guy",
year = "1982",
month = "5",
day = "5",
language = "English (US)",
volume = "43",
pages = "111--112",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "3",

}

TY - JOUR

T1 - Viloxazine HCl in the treatment of endogenous depression

T2 - A standard (imipramine) controlled clinical study

AU - McEvoy, Joseph Patrick

AU - Libiger, J.

AU - Wilson, W. H.

AU - Ban, T. A.

AU - Berney, S.

AU - Guy, W.

PY - 1982/5/5

Y1 - 1982/5/5

N2 - In a four week, double-blind clinical trial, 20 patients with endogenous depression were randomly assigned to treatment with either viloxazine or imipramine. Statistically significant improvement was observed on the Hamilton Psychiatric Rating Scales for Depression and Anxiety for both treatment groups. There were no differences between the two treatment groups in the type, incidence, or severity of treatment emergent symptoms. No medication-related abnormalities in clinical laboratory values occurred in either treatment group.

AB - In a four week, double-blind clinical trial, 20 patients with endogenous depression were randomly assigned to treatment with either viloxazine or imipramine. Statistically significant improvement was observed on the Hamilton Psychiatric Rating Scales for Depression and Anxiety for both treatment groups. There were no differences between the two treatment groups in the type, incidence, or severity of treatment emergent symptoms. No medication-related abnormalities in clinical laboratory values occurred in either treatment group.

UR - http://www.scopus.com/inward/record.url?scp=0020061738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020061738&partnerID=8YFLogxK

M3 - Article

C2 - 7037758

AN - SCOPUS:0020061738

VL - 43

SP - 111

EP - 112

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 3

ER -